Last updated on July 2020

Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis


Brief description of study

The objective of this study is to investigate the safety and efficacy of administering 372.6 mg of AK1820 (isavuconazonium sulfate) intravenously or orally to adult Japanese patients with deep mycosis. The primary endpoint is safety (percentage of patients with adverse events after starting the study treatment).

Clinical Study Identifier: NCT03471988

Find a site near you

Start Over

Research site

Naka-Ku, Japan
1.49miles
  Connect »

Research site

Kawasaki, Japan
7.04miles
  Connect »

Research site

Ota-Ku, Japan
9.24miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.